DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

GlaxoSmithKline (NYSE: GSK)

43.35 0.06 (0.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $43.35 0.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.08
Previous Close $43.29
Daily Range $42.98 - $43.58
52-Week Range $41.29 - $56.73
Market Cap $104.1B
P/E Ratio 14.88
Dividend (Yield) $2.45 (6.1%)
Ex-Dividend Date
Dividend Pay Date
11/05/14
01/08/15
Volume 3,510,085
Average Daily Volume 3,847,177
Current FY EPS $3.04

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

3 Beaten Down Stocks Ready to Bounce Back

Not all stocks had a great 2014. Here are three stocks that could be ready for a comeback.

Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog

The Early Retiree Portfolio For 2015

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More

Strength Seen in Agenus (AGEN): Stock Soars 17.2% - Tale of the Tape

GlaxoSmithKline (GSK) Stock Rises Today on Positive Experimental Shingles Vaccine Trial Results

Complex Sino-U.S. Ties Shine In Avon, Solar And Qualcomm Cases

Vanguard FTSE Europe ETF Experiences Big Outflow

Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

3 Reasons GlaxoSmithKline PLC Could Soar in 2015

GlaxoSmithKline shareholders have suffered through a rough year, but these three catalysts could send its stock soaring in 2015.

See More GSK News...

GSK's Top Competitors

GSK $43.35 (0.14%)
Current stock: GSK
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY